Seeking Alpha

NPS Pharmaceuticals (NPSP): Q1 EPS of -$0.12 misses by $0.01. Revenue of $22.2M (-3% Y/Y) misses...

NPS Pharmaceuticals (NPSP): Q1 EPS of -$0.12 misses by $0.01. Revenue of $22.2M (-3% Y/Y) misses by $1.7M. (PR)

Check out Seeking Alpha’s new Earnings Center »

From other sites
Comments (2)
  • SteveBoulay
    , contributor
    Comment (1) | Send Message
     
    This stock should be a double or more over the next 6-12 months on GATTEX approval, NATPARA approval and return of Sensipar Royatlies starting in 2013 mid-year. Assumsing a minimum of 5 years patent protection Sensipar should net 500m to the bottom line for NPSP
    4 May 2012, 04:53 AM Reply Like
  • Christopher Nassar
    , contributor
    Comments (6) | Send Message
     
    Still a very good stock to hold long-term.
    4 May 2012, 08:13 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs